V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Market Cap: 10.8B CHF
Have any thoughts about
Vifor Pharma AG?
Write Note

Vifor Pharma AG
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Net Income (Common) Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Net Income (Common)
CHf144.4m
CAGR 3-Years
-2%
CAGR 5-Years
-9%
CAGR 10-Years
-4%
Novartis AG
SIX:NOVN
Net Income (Common)
$16.2B
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
5%
Roche Holding AG
SIX:ROG
Net Income (Common)
CHf11.5B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
0%
S
Sandoz Group AG
SIX:SDZ
Net Income (Common)
$77m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Net Income (Common)?
Net Income (Common)
144.4m CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Net Income (Common) amounts to 144.4m CHF.

What is Vifor Pharma AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-4%

Over the last year, the Net Income (Common) growth was -60%. The average annual Net Income (Common) growth rates for Vifor Pharma AG have been -2% over the past three years , -9% over the past five years , and -4% over the past ten years .

Back to Top